blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3444612

EP3444612 - IMMUNOASSAY EMPLOYING SULFATED POLYSACCHARIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.01.2023
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  18.02.2022
FormerGrant of patent is intended
Status updated on  29.09.2021
FormerExamination is in progress
Status updated on  10.09.2021
FormerGrant of patent is intended
Status updated on  20.06.2021
FormerExamination is in progress
Status updated on  04.09.2020
FormerRequest for examination was made
Status updated on  18.01.2019
FormerThe international publication has been made
Status updated on  20.10.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
LSI Medience Corporation
13-4, Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
[2019/08]
Inventor(s)01 / SHIMIZU, Ryuhei
c/o LSI Medience Corporation
13-4 Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
02 / SHOJI, Keiichi
c/o LSI Medience Corporation
13-4 Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
03 / ZHANG, Xu
c/o LSI Medience Corporation
13-4 Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
 [2019/09]
Former [2019/08]01 / SHIMIZU Ryuhei
c/o LSI Medience Corporation
13-4
Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
02 / SHOJI Keiichi
c/o LSI Medience Corporation
13-4
Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
03 / Zhang Xu
c/o LSI Medience Corporation
13-4
Uchikanda 1-chome
Chiyoda-ku
Tokyo 101-8517 / JP
Representative(s)Cohausz & Florack
Patent- & Rechtsanwälte
Partnerschaftsgesellschaft mbB
Bleichstraße 14
40211 Düsseldorf / DE
[2019/08]
Application number, filing date17782424.012.04.2017
[2019/08]
WO2017JP14943
Priority number, dateJP2016008066013.04.2016         Original published format: JP 2016080660
[2019/08]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017179611
Date:19.10.2017
Language:JA
[2017/42]
Type: A1 Application with search report 
No.:EP3444612
Date:20.02.2019
Language:EN
[2019/08]
Type: B1 Patent specification 
No.:EP3444612
Date:23.03.2022
Language:EN
[2022/12]
Search report(s)International search report - published on:JP19.10.2017
(Supplementary) European search report - dispatched on:EP11.11.2019
ClassificationIPC:G01N33/531, G01N33/48, G01N33/53, G01N33/543
[2019/50]
CPC:
G01N33/5306 (EP,US); G01N33/548 (KR); G01N33/536 (KR);
G01N33/54326 (KR); G01N33/54333 (EP); G01N2333/7155 (KR);
G01N2400/18 (EP); G01N2400/22 (EP); G01N2400/40 (EP) (-)
Former IPC [2019/08]G01N33/531, G01N33/48, G01N33/53
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/08]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:IMMUNOASSAY UNTER VERWENDUNG VON SULFATIERTEM POLYSACCHARID[2019/08]
English:IMMUNOASSAY EMPLOYING SULFATED POLYSACCHARIDE[2019/08]
French:DOSAGE IMMUNOLOGIQUE UTILISANT UN POLYSACCHARIDE SULFATÉ[2021/43]
Former [2019/08]DOSAGE IMMUNOLOGIQUE UTLISANT UN POLYSACCHARIDE SULFATÉ
Entry into regional phase11.10.2018Translation filed 
11.10.2018National basic fee paid 
11.10.2018Search fee paid 
11.10.2018Designation fee(s) paid 
11.10.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
11.10.2018Examination requested  [2019/08]
29.04.2020Amendment by applicant (claims and/or description)
04.09.2020Despatch of a communication from the examining division (Time limit: M02)
23.10.2020Reply to a communication from the examining division
21.06.2021Communication of intention to grant the patent
08.09.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
08.09.2021Fee for grant paid
08.09.2021Fee for publishing/printing paid
07.10.2021Communication of intention to grant the patent
15.02.2022Receipt of the translation of the claim(s)
Opposition(s)02.01.2023No opposition filed within time limit [2023/09]
Fees paidRenewal fee
18.04.2019Renewal fee patent year 03
21.04.2020Renewal fee patent year 04
19.04.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.04.2017
AL23.03.2022
AT23.03.2022
CY23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
MK23.03.2022
MT23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SI23.03.2022
SK23.03.2022
SM23.03.2022
TR23.03.2022
IE12.04.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
[2024/42]
Former [2024/29]HU12.04.2017
AL23.03.2022
AT23.03.2022
CY23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
MK23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SI23.03.2022
SK23.03.2022
SM23.03.2022
TR23.03.2022
IE12.04.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2024/23]HU12.04.2017
AL23.03.2022
AT23.03.2022
CY23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
MK23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SI23.03.2022
SK23.03.2022
SM23.03.2022
IE12.04.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2024/20]HU12.04.2017
AL23.03.2022
AT23.03.2022
CY23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SI23.03.2022
SK23.03.2022
SM23.03.2022
IE12.04.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2024/18]HU12.04.2017
AL23.03.2022
AT23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SI23.03.2022
SK23.03.2022
SM23.03.2022
IE12.04.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/25]AL23.03.2022
AT23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SI23.03.2022
SK23.03.2022
SM23.03.2022
IE12.04.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/20]AL23.03.2022
AT23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
IE12.04.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/10]AL23.03.2022
AT23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
LU12.04.2022
BE30.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/09]AL23.03.2022
AT23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
LU12.04.2022
CH30.04.2022
LI30.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/08]AL23.03.2022
AT23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
LU12.04.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/07]AL23.03.2022
AT23.03.2022
CZ23.03.2022
DK23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/06]AL23.03.2022
AT23.03.2022
CZ23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
MC23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2023/01]AL23.03.2022
AT23.03.2022
CZ23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2022/51]AT23.03.2022
CZ23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
IS23.07.2022
PT25.07.2022
Former [2022/50]AT23.03.2022
CZ23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
NL23.03.2022
PL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
PT25.07.2022
Former [2022/49]AT23.03.2022
CZ23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
NL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SK23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
PT25.07.2022
Former [2022/48]AT23.03.2022
CZ23.03.2022
EE23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
NL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
PT25.07.2022
Former [2022/47]AT23.03.2022
FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
NL23.03.2022
RO23.03.2022
RS23.03.2022
SE23.03.2022
SM23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
PT25.07.2022
Former [2022/44]FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
NL23.03.2022
RS23.03.2022
SE23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
Former [2022/39]FI23.03.2022
HR23.03.2022
LT23.03.2022
LV23.03.2022
RS23.03.2022
SE23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
Former [2022/36]HR23.03.2022
LT23.03.2022
LV23.03.2022
RS23.03.2022
SE23.03.2022
BG23.06.2022
NO23.06.2022
GR24.06.2022
Former [2022/35]HR23.03.2022
LT23.03.2022
RS23.03.2022
SE23.03.2022
BG23.06.2022
NO23.06.2022
Former [2022/33]LT23.03.2022
NO23.06.2022
Documents cited:Search[A]WO02063302  (IMMUNOMATRIX INC [US]) [A] 2-10 * figure 2; example 1 *;
 [I]US2015369799  (MIYAZAWA TAKASHI [JP], et al) [I] 8-10 * paragraphs [0036] , [0037] , [0038]; table 1 *;
 [E]EP3373005  (FUJIREBIO KK [JP]) [E] 2-6* example 2; tables 1, 2, 3 *
International search[A]US4829009  (GRAVES HOWARD [US]) [A] 1-10 * , column 6, lines 32 to 58 (Family: none) *;
 [A]JP2002502979  (Biorad Pasteur) [A] 1-10 * , abstract & WO 1999/040442 A1 abstract & EP 1051623 A1 *;
 [XYA]JP2009053195  (ORTHO CLINICAL DIAGNOSTICS INC) [X] 1, 4-6, 8 * , abstract & US 8617820 B2 abstract & EP 2031392 A1 & CN 101377488 A & KR 10-2009-0023223 A * [Y] 7, 9-10 [A] 2, 3;
 [A]US2012045847  (LEWISCH SANDRA A [US], et al) [A] 1-10 * , paragraph [0045] & WO 2012/024416 A1 & EP 2606352 A1 *;
 [A]WO2012115221  (MITSUBISHI CHEM MEDIENCE CORP [JP], et al) [A] 1-10 * , abstract; example 2 & EP 2679997 A1 abstract; example 2 & JP 5864530 B2 & US 2013/0330841 A1 & CN 103380377 A & KR 10-2014-0007449 A *;
 [XYA]JP2013152247  (ABBOTT JAPAN CO LTD) [X] 1, 3-6, 8 * , abstract; claim 4 & JP 2010-127827 A * [Y] 7, 9-10 [A] 2;
 [EX]WO2017078119  (FUJIREBIO KK [JP]) [EX] 1-10* , paragraph [0055] & JP 2017-90132 A *;
 [Y]  - Anonymous, "DETAMINA CL IL -2R", Detamina CL IL -2R, (20110000), pages 1 - 6, XP009516377 [Y] 7, 9-10
 [X]  - SIEMENS HEALTHCARE DIAGNOSTICS KABUSHIKI KAISHA, "Siemens Immulyze IL -2R II", Pharmaceuticals and Medical Devices Agency, (20150000), pages 1 - 2, XP009516337 [X] 1, 5-7
 [A]  - DE JONGH R, "The Effects of Anticoagulation and Processing on Assays of IL -6, sIL-6R, sIL-2R and Soluble Transferrin Receptor", Cytokine, (19970901), vol. 9, no. 9, doi:10.1006/cyto.1997.0217, pages 696 - 701, XP055580009 [A] 1-10

DOI:   http://dx.doi.org/10.1006/cyto.1997.0217
 [A]  - COLLINSON P O, "Rapid troponin T measurement in whole blood for detection of myocardial damage", Ann Clin Biochem, (19950000), vol. 32, no. 5, pages 454 - 458, XP002086285 [A] 1-10
 [A]  - Anonymous, Serufuri N IL -2R, JP, (20100000), pages 1 - 6, URL: http://www.info.pmda.go.jp/downfiles/ivd/PDF/230187_22000AMX02422000_A_01_03.pdf, XP009516336 [A] 1-10
 [A]  - RYO TAKANO, "Sulfation and Desulfation of Polysaccharides: Effects of the Modification on their Properties", Kagaku to Seibutsu, (19960101), vol. 34, no. 9, doi:10.1271/kagakutoseibutsu1962.34.598, pages 598 - 604, XP055580020 [A] 1-10

DOI:   http://dx.doi.org/10.1271/kagakutoseibutsu1962.34.598
ExaminationUS2011136256
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.